Clinical Trial Update: Lemborexant in Delayed Sleep Phase Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating lemborexant for delayed sleep phase disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delaysed Sleep Phase Disorder

Drugs mentioned

• Dayvigo (Lemborexant) (lemborexant)

Snippet

Sponsor: University of California, San Francisco | Conditions: Delayed Sleep Phase Syndrome | Phase 4 | Status: RECRUITING